/IMNM

Immunome Inc

IMNM

$26.76USD↓-1.47%-0.40 today

MARKET CAP

3.0B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$27 – $27

52W RANGE

$9

$30

AI Summary

Stalk

StalkMedium

IMNM remains in a Stage 2 uptrend, but recent chop between the 9- and 20-EMA after a failed W-bottom near resistance has left timing unclear. Short-term EMAs have rolled and momentum is neutral despite overbought tag. Medium-term bias stays bullish around higher lows above key EMAs, so we will stalk dips into the 20-EMA and 50-SMA, awaiting clear re-acceleration above the 9-EMA before engaging.

↑High momentum factor indicates sustained share price uptrend.
↑Elevated institutional 13F ownership reflects growing investor confidence.
↓Negative earnings yield signals weak profitability.

Full analysis →

Buying

6

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
TR T. Rowe Price Investment Management, Inc. Q2 2026	BUY	19.68 M	416.95 M	+3.31 M	+16.5%	0.27%
BI Blackrock, Inc. Q2 2026	BUY	8.81 M	186.59 M	+636.82 K	+4.4%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	1.85 M	38.99 M	+-929.29 K	-27.3%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	1.62 M	35.34 M	+783.96 K	+97.7%	0.01%
WP Woodline Partners LP Q2 2026	SELL	1.00 M	21.20 M	+-2.15 M	-69.2%	0.07%
CA Citadel Advisors LLC Q2 2026	BUY	303.28 K	6.43 M	+127.58 K	+67.3%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	251.10 K	5.32 M	+182.20 K	+253.1%	0.01%
BH Brevan Howard Capital Management LP Q2 2026	BUY	25.27 K	535.41 K	+3.99 K	+15.1%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	11.78 K	249.62 K	+-6.95 K	-39.1%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-251.40 K	-100.0%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-130.37 K	-100.0%	0.00%